Yong-Jun Huh
Algemeen Directeur bij GREEN CROSS HOLDINGS CORPORATION
Vermogen: 17 M $ op 31-05-2024
Profiel
Yong-Jun Huh is currently the Co-Chief Executive Officer, Director & VP at Green Cross Holdings Corp.
and a Director at Artiva Biotherapeutics, Inc. He previously worked as a Director at GREEN CROSS WellBeing Corp.
and as an Executive Vice President at Green Cross Corp.
Huh holds an MBA from the University of Wisconsin and an undergraduate degree from Yonsei University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 12-06-2024 | 1 367 454 ( 2.91% ) | 14 M $ | 31-05-2024 | |
| 31-12-2022 | 300 000 ( 1.69% ) | 2 M $ | 31-05-2024 | |
GC CELL CORPORATION
0.20% | 30-09-2023 | 31 000 ( 0.20% ) | 759 019 $ | 31-05-2024 |
Actieve functies van Yong-Jun Huh
| Bedrijven | Functie | Begin |
|---|---|---|
| GREEN CROSS HOLDINGS CORPORATION | Algemeen Directeur | 01-03-2010 |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Directeur/Bestuurslid | 01-09-2019 |
Eerdere bekende functies van Yong-Jun Huh
| Bedrijven | Functie | Einde |
|---|---|---|
| GC BIOPHARMA CORP. | Corporate Officer/Principal | - |
| GREEN CROSS WELLBEING CORPORATION | Directeur/Bestuurslid | - |
Opleiding van Yong-Jun Huh
| Yonsei University | Undergraduate Degree |
| University of Wisconsin | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| GREEN CROSS HOLDINGS CORPORATION | Health Technology |
| GREEN CROSS WELLBEING CORPORATION | Health Technology |
| GC BIOPHARMA CORP. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
